Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 22, 2013CirculationOpen Access

Pathological Ventricular Remodeling

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

JBJana BurchfieldGoethe University FrankfurtMXMin XieHubei University of MedicineJHJoseph A. HillSouth African Medical Research Council

Discussion

Loading...

Member takes

Implication

Should not yet change heart failure practice; leaves open optimal multi-target combinations for prospective trials.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Burchfield et al. (2013) studied this question.

synapsesocial.com/papers/69d5724675589c71d767e69ehttps://doi.org/10.1161/circulationaha.113.001878

Topics

Heart failureHFrEF treatment
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure2001 · 3,993 citations
  2. 2Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice2006 · 340 citations
  3. 3Reverse remodelling in heart failure with cardiac resynchronisation therapy2006 · 82 citations
  4. 4Electrophysiological Consequences of Dyssynchronous Heart Failure and Its Restoration by Resynchronization Therapy2009 · 203 citations
  5. 5Mechanisms of Enhanced β-Adrenergic Reserve From Cardiac Resynchronization Therapy2009 · 121 citations